Screening for lung cancer: Does MRI have a role?

Area of Science:

• Medical Imaging
• Radiology
• Oncology

Background:

• National low dose computed tomography (LDCT) lung cancer screening programs are established in the USA, while other countries await trial results.
• Advancements in magnetic resonance imaging (MRI) technology present lung MRI as a viable alternative to CT for lung cancer detection.
• Existing studies indicate lung MRI's effectiveness in detecting solid lung nodules, with high detection rates for various lesion sizes.

Purpose of the Study:

• To review the technical potential of lung MRI for early lung cancer detection.
• To explore implementation scenarios for lung MRI in lung cancer screening programs.
• To discuss the hypothesis that lung MRI may offer similar sensitivity to LDCT with improved specificity.

Main Methods:

• Review of experimental and clinical studies on lung MRI for nodule detection.
• Discussion of technical advancements enabling robust lung MRI protocols.
• Consideration of biological features of lung cancer for multi-parametric MRI characterization.

Main Results:

• Lung MRI demonstrates high sensitivity for solid nodules (60-100% for 5-8mm+ lesions).
• Expected high sensitivity for non-solid lesions, though data on adenocarcinoma is sparse.
• Standardized protocols and improved image quality make lung MRI increasingly feasible.

Conclusions:

• Lung MRI is technically ready for large-scale prospective lung cancer screening trials.
• The hypothesis suggests lung MRI could achieve high sensitivity and better specificity than LDCT.
• Further research will determine optimal screening thresholds, cost-effectiveness, and patient outcomes.